Xconomy | Boston - Business + Technology in the Exponential Economy

EqualLogic’s Record-Setting Sale, ExaGrid’s Sizable Third Round, and the Rest of Last Week’s Deals
Resolvyx gets $25 Million in Financing to Turn Fish-Oil Science into New Drugs
Quanterix Collects $15 Million in Series A Venture Round
Agios, Developer of Drugs That Starve Cancer Cells, Scarfs Up $33 Million in Venture Funds
Another Big Venture Round for Acceleron Pharma

Ensemble Discovery Completes $15 Million Financing

Cambridge-based Ensemble Discovery, which is developing therapeutics and bioassays using its proprietary “DNA-programmed chemistry” platform, has completed a $15 million Series B funding round, PE Week reported. The three-year-old company received a first tranche payment of $10 million back in January, with the remainder just announced. Participants in the round included Aeneas Venture (Harvard Management Company), ARCH Venture Partners, Boston University Technology Development Fund, CMEA Ventures, Flagship Ventures, Harris & Harris Group, and Oxford Bioscience Partners.

Comments | Permalink |